Please read the post closely. It was Falconeer that posted that statement on his post #83059 where he took issue with Feuerstein calling posters here profoundly stupid. Please review his background and posts. I (drv17) am not debating anyone.
Valued at $25? This company's lead compound alone may be valued above $30 billion in market cap based on Biogen false flag run up.. and that was just one IND- Alzheimer's. The minimum valuation for Anavex is $50 billion (or $1000 per share) with Sigmaceptor platform, A3-71 et al.. drug assets, and current SOC -15 month stabilization ( maybe reversal) for Alzheimer's . Not including other possible IND's
All that makes the $1 estimate is more sickeningly wrong than those selling Anavex at $170 million...